Due Diligence

During the due diligence process, data privacy has emerged as a pivotal element in both financial and commercial due diligence for mergers and acquisitions. When assessing a target company, especially in the biotech, medical device, or AI sectors, it is crucial to ensure that data collection and processing complies with regulations. This is a key step to mitigate potential regulatory setbacks. It's vital to delve into the data room to ascertain the methods the company uses for health data collection, identify any red flags regarding secondary use intentions, and confirm that basic security measures are in place. As we navigate an era where privacy regulations are rapidly expanding, understanding the requirements of these laws during legal due diligence, prior to finalizing term sheets, warranties, and valuations, becomes paramount

Contact us

How can iliomad Health Data help you ?

iliomad Health Data partners with Life Sciences investment funds during the diligence process, delivering in-depth privacy reports on target life sciences companies. These assessments, available in a structured data room, give a holistic perspective on the health data privacy lifecycle, encompassing stages from initial data gathering to subsequent reuse and data hosting. Through operational due diligence and audits, potential risks linked to privacy concerns are pinpointed. This critical information from iliomad Health Data provides indispensable insights that shape and refine investment choices.

Responsibility assessment
Data transfer and data hosting
Data governance
Gap analysis
Contractual review
Risk analysis